title: First case of mirtazepine-induced Stevens-Johnson syndrome from India.
abstract: A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were suggestive of Stevens-Johnson syndrome. This is a rare adverse effect of the newer generation antidepressant mirtazepine.
authors.affiliation: Department of Medicine, Lady Hardinge Medical College, New Delhi, India.
authors.forename: Amit
authors.initials: A
authors.lastname: Bhasin
authors.forename: Anil
authors.initials: A
authors.lastname: Gurtoo
authors.forename: Latika
authors.initials: L
authors.lastname: Gupta
authors.forename: Gunjan
authors.initials: G
authors.lastname: Aggarwal
mesh_terms: D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007194:India; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives*; D000078785:Mirtazapine; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000175:diagnosis*
chemical_list: D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine
keywords: Mirtazepine; Stevens-Johnson syndrome; systemic lupus erythematosus